Steve Chrzanowski
@stevechrz
Assistant Professor @UMassChan’s Duchenne Program via @UofCincy → @UFMedicine → @TheBCRP → @BCHNeuroRes → @harvardneuromds • Tweets my own • RT≠endorsement
ID: 42793018
https://connects.catalyst.harvard.edu/Profiles/display/Person/169399 27-05-2009 02:26:19
1,1K Tweet
897 Followers
409 Following
When Brian Wallach was diagnosed with ALS, he was given six months to live. Brian Wallach and Sandra Abrevaya’s film, For Love & Life: No Ordinary Campaign, chronicles their incredible journey, and proves that all of us are far more powerful than we know. I hope you’ll watch it on Prime
Current Boston Children’s Child Neurology & NDD Residency chief Dr. Santana does an excellent job highlighting the overlap between considerations of inflammatory myopathies and laminopathies. urldefense.com/v3/__http://do…
NEW #openaccess article by Alexandra Santana Almansa & Boston Children's colleagues: "LMNA-related #musculardystrophy presenting as an inflammatory myopathy" onlinelibrary.wiley.com/doi/10.1002/cn… AlexandraSantanaAlmansa Steve Chrzanowski Farrah Rajabi Megan Day-Lewis Wiley Neuro
Grateful for the opportunity to learn from some of the best Neuromuscular specialists at Boston Children’s Child Neurology & NDD Residency, Brigham and Women's Neurology, and MGH Neurology this past year. Onwards and upwards!
5y of Bioengineering University of Cincinnati, 8y of MD-PhD FLORIDA, 2y of Pediatrics Residency @TheBCRP, 3y of Child Neurology Residency Boston Children’s Child Neurology & NDD Residency, and 1y of Neuromuscular Fellowship at MGH Neurology and Brigham and Women's Neurology. Excited for a future of caring for patients & families with NM disorders!
Im thrilled to join UMass Chan Department of Neurology and the great opportunities ahead. Onward and upward!
Way to go Rosha Poudyal!
Terrific news, thank you to Maura Healey. Terrific work by our friends between Parent Project Muscular Dystrophy (PPMD), CureDuchenne, Muscular Dystrophy Association, Brigham and Women's Hospital, UMass Chan Medical School, and all of those involved. parentprojectmd.org/duchenne-added…
As an early investor in Dyne Therapeutics #CureDuchenne is pleased to share that Dyne announced positive data from their Phase 1/2 trial of DYNE-251 in individuals with #Duchenne amenable to skipping exon 51. #DMD #Duchenne #FDA #Research #ExonSkipping cureduchenne.org/general/dyne-t…